Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Smith

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Haematologica|January 25, 2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|November 13, 2010
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Blood|December 10, 2009
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemiaDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
Lancet (London, England)|May 27, 2014
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiologyBrian McCloskey, Tina Endericks, Mike Catchpole, et al.
Scientific Reports|November 21, 2019
Publisher Correction: Combining Biomarkers with EMR Data to Identify Patients in Different Phases of SepsisIshan Taneja, Bobby Reddy, Gregory Damhorst, et al.
Scientific Reports|September 9, 2017
Combining Biomarkers with EMR Data to Identify Patients in Different Phases of SepsisIshan Taneja, Bobby Reddy, Gregory Damhorst, et al.
Emerging Infectious Diseases|July 14, 2011
Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United KingdomRichard G Pebody, Ross Harris, George Kafatos, et al.
Open Forum Infectious Diseases|December 22, 2023
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020Nadezhda Duffy, Rongxia Li, Christopher A Czaja, et al.
Microbiology Spectrum|April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. SitesJoseph D Lutgring, Julian E Grass, David Lonsway, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Haematologica|January 25, 2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|November 13, 2010
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Blood|December 10, 2009
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemiaDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
Lancet (London, England)|May 27, 2014
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiologyBrian McCloskey, Tina Endericks, Mike Catchpole, et al.
Scientific Reports|November 21, 2019
Publisher Correction: Combining Biomarkers with EMR Data to Identify Patients in Different Phases of SepsisIshan Taneja, Bobby Reddy, Gregory Damhorst, et al.
Scientific Reports|September 9, 2017
Combining Biomarkers with EMR Data to Identify Patients in Different Phases of SepsisIshan Taneja, Bobby Reddy, Gregory Damhorst, et al.
Emerging Infectious Diseases|July 14, 2011
Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United KingdomRichard G Pebody, Ross Harris, George Kafatos, et al.
Open Forum Infectious Diseases|December 22, 2023
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020Nadezhda Duffy, Rongxia Li, Christopher A Czaja, et al.
Microbiology Spectrum|April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. SitesJoseph D Lutgring, Julian E Grass, David Lonsway, et al.
Pageof 14